This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.
Approval for the ventana alk (d5f3) cdx assay. This device is indicated for the following:ventana alk (d5f3) cdx assay is intended for the qualitative detection of the anaplastic lymphoma kinase (alk) protein in formalin-fixed, paraffin-embedded (ffpe) non-small cell lung carcinoma (nsclc) tissue stained with a benchmark xt automated staining instrument. It is indicated as an aid in identifying patients eligible for treatment with xalkori® (crizotinib).
Device | VENTANA ALK (D5F3) CDX ASSAY |
Classification Name | Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Generic Name | Immunohistochemistry Assay, Antibody, Anaplastic Lymphoma Kinase |
Applicant | VENTANA MEDICAL SYSTEMS, INC. |
Date Received | 2014-11-14 |
Decision Date | 2015-06-12 |
Notice Date | 2015-07-10 |
PMA | P140025 |
Supplement | S |
Product Code | PKW |
Docket Number | 15M-2219 |
Advisory Committee | Pathology |
Expedited Review | No |
Combination Product | Yes |
Applicant Address | VENTANA MEDICAL SYSTEMS, INC. 1910 East Innovation Park Dr. tucson, AZ 85755 |
Summary: | Summary of Safety and Effectiveness |
Labeling: | Labeling |
Approval Order: | Approval Order |
Supplement Number | Date | Supplement Type |
---|---|---|
P140025 | Original Filing | |
S018 | 2022-07-12 | 30-day Notice |
S017 | 2022-02-16 | Special (immediate Track) |
S016 | 2022-01-28 | 135 Review Track For 30-day Notice |
S015 | 2021-02-22 | Real-time Process |
S014 | 2020-11-16 | Normal 180 Day Track |
S013 | 2020-08-26 | Real-time Process |
S012 | 2020-01-13 | Real-time Process |
S011 | 2019-08-22 | Real-time Process |
S010 | 2018-11-09 | 30-day Notice |
S009 | 2018-06-18 | Real-time Process |
S008 | ||
S007 | 2017-07-17 | 30-day Notice |
S006 | 2017-06-07 | Normal 180 Day Track |
S005 | 2016-12-28 | Normal 180 Day Track |
S004 | 2016-11-15 | Normal 180 Day Track |
S003 | 2016-03-22 | Normal 180 Day Track |
S002 | 2015-12-10 | 135 Review Track For 30-day Notice |
S001 | 2015-08-26 | 30-day Notice |